Try the modernized ClinicalTrials.gov beta website. Learn more about the modernization effort.
Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Isoquercetin in Sickle Cell Anemia

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT04474626
Recruitment Status : Withdrawn (Trial did not activate)
First Posted : July 17, 2020
Last Update Posted : January 11, 2021
Sponsor:
Collaborator:
Quercegen Pharmaceuticals
Information provided by (Responsible Party):
Jeffrey Zwicker, MD, Beth Israel Deaconess Medical Center

No Study Results Posted on ClinicalTrials.gov for this Study
Study was withdrawn before participants were enrolled.
Recruitment Status : Withdrawn
Estimated Primary Completion Date : December 31, 2022
Estimated Study Completion Date : December 31, 2024